Raymond James Financial Services Advisors, Inc. Abb Vie Inc. Transaction History
Raymond James Financial Services Advisors, Inc.
- $73.5 Billion
- Q3 2024
A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 1,124,281 shares of ABBV stock, worth $197 Million. This represents 0.3% of its overall portfolio holdings.
Number of Shares
1,124,281
Previous 1,092,152
2.94%
Holding current value
$197 Million
Previous $187 Million
18.52%
% of portfolio
0.3%
Previous 0.27%
Shares
30 transactions
Others Institutions Holding ABBV
# of Institutions
3,852Shares Held
1.25BCall Options Held
16.8MPut Options Held
12.2M-
Vanguard Group Inc Valley Forge, PA172MShares$30.1 Billion0.62% of portfolio
-
Black Rock Inc. New York, NY136MShares$23.9 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.1MShares$13.9 Billion0.65% of portfolio
-
Jpmorgan Chase & CO New York, NY52.1MShares$9.14 Billion0.84% of portfolio
-
Morgan Stanley New York, NY38.7MShares$6.79 Billion0.56% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $310B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...